Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989
Nifedipine in the Prophylaxis of Classic Migraine:A Crossover, Double-Masked, Placebo-Controlled Study of Headache
Neurol 39:284-286, McArthur,J.C.,et al, 1989
Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989
Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989
PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988
Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988
Improvement of Hepatic Encephalopathy Treated with Flumazenil
Lancet 2:1392-1394, Grimm,G.,et al, 1988
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Parkinsonism, Tremor, and Depression Induced by Cinnarizine and Flunarizine
BMJ 297:722-723, Capella,D.,et al, 1988
Combination of Aminocaproic Acid & Nicardipine in Treatment of Aneurysmal Subarachnoid Hemorrhage
Stroke 19:63-67, Beck,D.W.,et al, 1988
A Controlled Trial of Nimodipine in Acute Ischemic Stroke
NEJM 318:203-207, Gelmers,H.J.,et al, 1988
Tardive Dyskinesia
BMJ 296:150-151, Barnes,T.R.E., 1988
International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988
Hyperhidrosis & Hypothermia Responsive to Oxybutynin
Neurol 38:506-507, LeWitt,P., 1988
Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988
Nifedipine for Epilepsy? A Pilot Study
BMJ 296:530-531, Larkin,J.G.,et al, 1988
Pharmacotherapy for Aphasia
Neurol 38:877-879, Albert,M.L.,et al, 1988
Magnetic Resonance Imaging in Familial Paroxysmal Ataxia
Arch Neurol 45:547-549, Vighetto,A.,et al, 1988
Eye Pain with Nifedipine & Disturbance of Taste with Captopril
BMJ 296:1086-1088, Coulter,D.M., 1988
A Double-Blind Randomized Crossover Trial of Bromocriptine & Placebo in Restless Legs Syndrome
Ann Neurol 24:455-458, Walters,A.S.,et al, 1988
Reduced Felodipine Bioavailability in Pts Taking Anticonvulsants
Lancet 2:480-482, Capewell,S.,et al, 1988
Effect of Chronic Treatment with the Calcium Antagonist Diltiazem in Duchenne Muscular Dystrophy
Neurol 38:609-613, Bertorini,T.E.,et al, 1988
Uneven Pattern of Dopamine Loss in the Striatum with Idiopathic Parkinson's Disease, Pathophysiologic & Clinical Implications
NEJM 318:876-880, Kish,S.J., 1988
Progressive Language Impairment without Dementia:A Case with Isolated Category Specific Semantic Defect
JNNP 51:1201-1207, Basso,A.,et al, 1988
Dopamine Agonists, In Parkinson's Disease and Movement Disorders
Urban & Schwarzenberg, Balt, p. 104., Jankovic,J.&Tolosa,E., 1988
Hereditary Dentatorubral-Pallidoluysian Atrophy:Clinical and Pathologic Variants in a Family
Neurol 38:1065-1070, Takahashi,H.,et al, 1988
Posterior Cortical Atrophy
Arch Neurol 45:789-793, Benson,D.F.,et al, 1988
The Dandy-Walker Syndrome
In Handbk of Clin Neurology, Elsevier Publ, Amsterdam, 50:32387., Epstein,M.H.&Johanson,C.E., 1987
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
Pituitary Growth Hormone from Human Cadavers:Neurologic Disease in Ten Recipients
Neurol 37:1211-1213, Rappaport,E.B.&Graham,D.J., 1987
Treatment of Myotonia
Editorial, Lancet 1:1242-12441987., , 1987
Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987
Cerebral Ischemia with Mitral Valve Prolapse
Am Heart J 113:1308-1315, Wolf,P.A.,et al, 1987
Prions & Neurodegenerative Diseases
NEJM 317:1571-1581, 15971987., Prusiner,S.B., 1987
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987
Aggravation of Parkinson's Disease by Cinnarizine
JNNP 50:804-805, Marti-Masso,J.F.,et al, 1987
Brain Cardioembolism, Issues in Diagnosis & Management
Postgrad Med 82:48-57, Anderson,D.C., 1987
A Multicenter Study of Anticoagulation Parameters When Using Heparin & Warfarin
Arch Neurol 44:1229-1231, Alberts,M.J.,et al, 1987
Effect of Calcium Antagonists on the Cerebral Circulation
(Supplement) Am J Cardiol 59:173B-176B987., Gelmers,H.J., 1987
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986
Current Concepts in Brain Resuscitation
Arch Int Med 146:1413-1419, Kirsch,J.R.,et al, 1986
Fatal Familial Insomnia & Dysautonomia with Selective Degeneration of Thalamic Nuclei
NEJM 315:997-1003, Lugaresi,E.,et al, 1986
Nifedipine-Associated Acute Psychosis
Am J Med 81:705-706, Kahn,J.K., 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Verapamil Potentiates Carbamazephine Neurotoxicity:A Clinically Important Inhibitory Interaction
Lancet 1:700-703, Macphee,G.A.,et al, 1986
Carbamazepine Neurotoxicity Precipitated by Dilitiazem
BMJ 292:1170-1171, Brodie,M.J.,et al, 1986